No conviction changes recorded
Upgrade to premium to see the full reasoning behind each conviction change.
Sign in to unlockFair Value Distribution — percentile bands
100.0% of simulations place fair value above current price
WHAT IS PRICED IN
Revenue-Based Reverse DCF
-8.1%/yr
±2.5% · revenue growth to justify current price
FCF-Based Reverse DCF
-19.4%/yr
±0.8% · FCF growth to justify current price
THE GAP
Market pricing margin expansion or capex normalization
Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.
Sign in to unlockViterra integration adds 40% capacity in oilseed processing and diversifies into Canadian/Australian origins. Normalized EBITDA path to $3B+ is credible if synergies realized. Grain trading cycle is late-stage but Bunge's distribution network is irreplaceable.
Commodity price headwinds if grain cycles turn (La Nina ending). $14B debt is heavy — rising rates materially increase interest burden. Integration risk: Viterra culture clash, IT systems, regulatory requirements in multiple jurisdictions.
Viterra synergy realization below $300M by year 2, grain commodity price decline >20%, credit downgrade
Updated Mar 17
Bunge's Viterra integration is the key investment thesis. High leverage is manageable if synergies realized; cyclical commodity exposure is elevated given FY2025 strength.